ZA874255B - Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers - Google Patents

Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers

Info

Publication number
ZA874255B
ZA874255B ZA874255A ZA874255A ZA874255B ZA 874255 B ZA874255 B ZA 874255B ZA 874255 A ZA874255 A ZA 874255A ZA 874255 A ZA874255 A ZA 874255A ZA 874255 B ZA874255 B ZA 874255B
Authority
ZA
South Africa
Prior art keywords
thioethers
substituted ethers
oxabicycloheptane substituted
hydroximic acids
hydroximic
Prior art date
Application number
ZA874255A
Other languages
English (en)
Inventor
Ravi Kannadikovilakom Varma
Kannadikovilakom Varma Ravi
Eric Michael Gordon
Michael Gordon Eric
Ligaya Magbanua Simpkins
Magbanua Simpkins Ligaya
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA874255B publication Critical patent/ZA874255B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA874255A 1986-07-23 1987-06-12 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers ZA874255B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (1)

Publication Number Publication Date
ZA874255B true ZA874255B (en) 1988-02-24

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874255A ZA874255B (en) 1986-07-23 1987-06-12 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers

Country Status (29)

Country Link
US (1) US4673685A (fr)
JP (1) JP2557894B2 (fr)
KR (1) KR950010596B1 (fr)
AT (1) AT397094B (fr)
AU (1) AU599384B2 (fr)
BE (1) BE1000141A3 (fr)
CA (1) CA1292003C (fr)
CH (1) CH674010A5 (fr)
DD (1) DD263990A5 (fr)
DE (1) DE3724152A1 (fr)
DK (1) DK383587A (fr)
ES (1) ES2006784A6 (fr)
FI (1) FI873207A (fr)
FR (1) FR2601953B1 (fr)
GB (1) GB2192882B (fr)
GR (1) GR871147B (fr)
HU (1) HU198495B (fr)
IE (1) IE60487B1 (fr)
IL (1) IL82919A0 (fr)
IT (1) IT1222054B (fr)
LU (1) LU86949A1 (fr)
NL (1) NL8701742A (fr)
NO (1) NO168359C (fr)
NZ (1) NZ220677A (fr)
PH (1) PH23711A (fr)
PT (1) PT85381B (fr)
SE (1) SE8702936L (fr)
YU (1) YU46321B (fr)
ZA (1) ZA874255B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (fr) * 1979-01-05 1984-04-04 National Research Development Corporation Intermédiaires pour la synthèse de bicyclo (2,2,1) heptanes et bicyclo (2,2,1) hept-2Z-ènes
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
EP0082646B1 (fr) * 1981-12-23 1989-11-15 National Research Development Corporation Prostaglandines
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (fr) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptanes substitues analogues de prostaglandines
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
HU198495B (en) 1989-10-30
HUT47115A (en) 1989-01-30
AU7444887A (en) 1988-01-28
JPS6335576A (ja) 1988-02-16
AT397094B (de) 1994-01-25
ATA174887A (de) 1993-06-15
NO873069L (no) 1988-01-25
YU46321B (sh) 1993-05-28
ES2006784A6 (es) 1989-05-16
KR950010596B1 (ko) 1995-09-20
US4673685A (en) 1987-06-16
PH23711A (en) 1989-09-27
NO168359B (no) 1991-11-04
IE871675L (en) 1988-01-23
LU86949A1 (fr) 1988-02-02
IE60487B1 (en) 1994-07-27
DK383587D0 (da) 1987-07-22
CH674010A5 (fr) 1990-04-30
IT1222054B (it) 1990-08-31
GR871147B (en) 1987-12-04
FI873207A0 (fi) 1987-07-21
NO873069D0 (no) 1987-07-22
IL82919A0 (en) 1987-12-20
SE8702936L (sv) 1988-04-07
PT85381A (en) 1987-08-01
PT85381B (pt) 1990-04-30
FI873207A (fi) 1988-01-24
DK383587A (da) 1988-01-24
GB8714621D0 (en) 1987-07-29
NZ220677A (en) 1989-12-21
CA1292003C (fr) 1991-11-12
NL8701742A (nl) 1988-02-16
GB2192882A (en) 1988-01-27
FR2601953A1 (fr) 1988-01-29
BE1000141A3 (fr) 1988-05-03
YU138187A (en) 1988-12-31
JP2557894B2 (ja) 1996-11-27
IT8721328A0 (it) 1987-07-16
KR880001660A (ko) 1988-04-25
NO168359C (no) 1992-02-12
DD263990A5 (de) 1989-01-18
SE8702936D0 (sv) 1987-07-22
FR2601953B1 (fr) 1990-11-16
DE3724152A1 (de) 1988-02-04
AU599384B2 (en) 1990-07-19
GB2192882B (en) 1990-05-09

Similar Documents

Publication Publication Date Title
IL75533A0 (en) Preparation of heteroaryloxyacetamides
GB2176478B (en) Deprotection of allylic esters and ethers
GB2192882B (en) Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers
IL80305A0 (en) Preparation of epsilon-butyrolactams
GB8507789D0 (en) Preparation of 2-amino-s-triazines
GB8529729D0 (en) Preparation of fish-noodles
DE3661736D1 (en) Preparation of surfactants
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
AU574852B2 (en) 13 - acyloxy - 5 - ketomilbemycin derivatives and preparation of 13 - hydroxy - 5 - ketomilbemycin derivatives
IL78379A0 (en) Preparation of 2- ercaptobenzoxazoles
IL76249A (en) Preparation of fluoroformates
DE3566540D1 (en) Preparation of fluoropyridines
AU567734B2 (en) Preparation of 20-keto-delta 16 - steroids and intermediates
DE3276871D1 (en) Preparation of 6-deoxy-d-fructose and 6-deoxy-l-sorbose
IL78977A0 (en) Preparation of alkyloxiranes
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8422162D0 (en) Preparation of alkyfurans
GB8520403D0 (en) Preparation of aminolactone
DE3566532D1 (en) Preparation of 4-fluorophenols
AU552189B2 (en) Substitute oxo-piperazines and preparation of pyrazing- isoquinolines therefrom
NZ232269A (en) Preparation of 4-demethoxy-daunomycinone and 4-demethoxy-7-deoxy-daunomycinone
AU6764787A (en) Hydroxamic acids of 7-oxabicycloheptane substituted ethers
IE860394L (en) Preparation of arylglycidyl ethers and alkylaminopropandiol¹derivatives
IL80245A0 (en) Preparation of 2-alkylsulphonyl-alkylenepyrimidines
ZA8550B (en) Esters of anthracyclines